Get Premium to unlock powerful stock data
NAS:SNY (France)  
Sanofi SA logo

Sanofi SA

$ 50.18 -0.83 (-1.63%) 10:08 PM EST
On watch
P/E:
19.62
P/B:
1.77
Market Cap:
$ 125.32B
Enterprise V:
$ 137.42B
Volume:
1.49M
Avg Vol (2M):
2.56M
Also Trade In:
Volume:
1.49M
Market Cap $:
125.32B
PE Ratio:
19.62
Avg Vol (2-Month):
2.56M
Enterprise Value $:
137.42B
PB Ratio:
1.77
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Description
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Financials (Next Earnings Date:2022-07-28)

SNY's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:SNY

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 45,608.134
EPS (TTM) ($) 2.879
Beta 0.55
Volatility % 15.74
14-Day RSI 43.55
14-Day ATR ($) 1.189944
20-Day SMA ($) 51.068
12-1 Month Momentum % 2.22
52-Week Range ($) 46.925 - 58.1
Shares Outstanding (Mil) 2,497.32

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sanofi SA Filings

Document Form Filing Date
No Filing Data

Headlines

See More